Memantine abolishes the formation of cocaine-induced conditioned place preference possibly via its IL-6-modulating effect in medial prefrontal cortex

Behavioural Brain Research

Volumn 220, Issue 1, 2011, Pages 126-131

  Lin, Kuei Ying ^a   Cherng, Chianfang G ^b   Yang, Fu Rong ^a   Lin, Li Ching ^a   Lu, Ru Band ^a   Yu, Lung ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

Cocaine memory; Conditioning; Cytokine; Memantine; Nucleus accumbens

Indexed keywords

COCAINE; DOPAMINE; INTERLEUKIN 6; MEMANTINE; RECOMBINANT INTERLEUKIN 6; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; DOPAMINE METABOLISM; DRUG DOSE REGIMEN; IMMUNOMODULATION; LOCOMOTION; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SINGLE DRUG DOSE;

3,4-DIHYDROXYPHENYLACETIC ACID; ANALYSIS OF VARIANCE; ANESTHETICS, LOCAL; ANIMALS; COCAINE; CONDITIONING, OPERANT; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MEMANTINE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; THALIDOMIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79951807404     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.01.031     Document Type: Article

References (29)

1. Boudreau A.C., Wolf M.E. Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus accumbens. J Neurosci 2005, 25:9144-9151.
2. Cornish J.L., Kalivas P.W. Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci 2000, 20:RC89.
3. Gass J.T., Olive M.F. Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol 2008, 75:218-265.
4. Uys J.D., LaLumiere R.T. Glutamate: the new frontier in pharmacotherapy for cocaine addiction. CNS Neurol Disord Drug Targets 2008, 7:482-491.
5. William J.M., Steketee J.D. Cocaine increases medial prefrontal cortical glutamate overflow in cocaine-sensitized rats: a time course study. Eur J Neurosci 2004, 20:1639-1646.
6. Bespalov A.Y., Dravolina O.A., Zvartau E.E., Beardsley P.M., Balster R.L. Effects of NMDA receptor antagonists on cocaine-conditioned motor activity in rats. Eur J Pharmacol 2000, 390:303-311.
7. Scheggi S., Mangiavacchi S., Masi F., Gambarana C., Tagliamonte A., De Montis M.G. Dizocilpine infusion has a different effect in the development of morphine and cocaine sensitization: behavioral and neurochemical aspects. Neuroscience 2002, 109:267-274.
8. Maldonado C., Rodríguez-Arias M., Castillo A., Aguilar M.A., Miñarro J. Effect of memantine and CNQX in the acquisition, expression and reinstatement of cocaine-induced conditioned place preference. Prog Neuropsychopharm Biol Psychiatry 2007, 31:932-939.
9. Newman J.L., Beardsley P.M. Effects of memantine, haloperidol, and cocaine on primary and conditioned reinforcement associated with cocaine in rhesus monkeys. Psychopharmacology (Berl) 2006, 185:142-149.
10. Collins E.D., Vosberg S.K., Ward A.S., Haney M., Foltin R.W. The effects of acute pretreatment with high-dose memantine on the cardiovascular and behavioral effects of cocaine in humans. Exp Clin Psychopharmacol 2007, 15:228-237.
11. Vosburg S.K., Hart C.L., Haney M., Foltin R.W. An evaluation of the reinforcing effects of memantine in cocaine-dependent humans. Drug Alcohol Depend 2005, 79:257-260.
12. Wu H.M., Tzeng N.S., Qian L., Wei S.J., Hu X., Chen S.H. Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation. Neuropsychopharmacology 2009, 34:2344-2357.
13. Blanchard A.P., Guillemette G., Boulay G. Memantine potentiates agonist-induced Ca2+ responses in HEK 293 cells. Cell Physiol Biochem 2008, 22:205-214.
14. Ke J.-J., Chen H.-I., Jen C.J., Kuo Y.-M., Cherng C.G., Tsai Y.N., et al. Mutual enhancement of central neurotoxicity induced by ketamine followed by methamphetamine. Toxicol Appl Pharmacol 2008, 227:239-247.
15. Kuhar M.J., Ritz M.C., Boja J.W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 1991, 14:299-302.
16. Trecki J., Unterwald E.M. Modulation of cocaine0induced activity by intracerebral administration of CXCL12. Neuroscience 2009, 161:13-22.
17. Cherng C.G., Tsai C.-W., Tsai Y.-P., Ho M.-C., Kao S.-F., Yu L. Methamphetamine-disrupted sensory processing mediates conditioned place preference performance. Behav Brain Res 2007, 182:103-108.
18. Menendez-Gonzalez M., Calatayud M.T., Blazquez-Menes B. Exacerbation of Lewy bodies dementia due to memantine. J Alzheimers Dis 2005, 8:289-291.
19. Moellentin D., Picone C., Leadbetter E. Memantine-induced myclonus and delirium exacerbated by trimethoprim. Ann Pharmacother 2008, 42:443-447.
20. Fan H.-Y., Cherng C.G., Yang F.-Y., Cheng L.-Y., Tsai C.-J., Lin L.-C., et al. Systemic treatment with protein synthesis inhibitors attenuates the expression of cocaine memory. Behav Brain Res 2010, 208:522-527.
21. Robinson T.E., Kolb B. Alterations in the morphology of dentrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment amphetamine and cocaine. Eur J Neurosci 1999, 11:1598-1604.
22. Nakajima A., Yamada K., Nagai T., Uchiyama T., Miyamoto Y., Mamiya T., et al. Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity. J Neurosci 2004, 24:2212-2225.
23. Niwa M., Nitta A., Yamada K., Nabeshima T. The roles of glial cell line-derived neurotrophic factor, tumor necrosis factor-alpha, and an inducer of these factors in drug dependence. J Pharmacol Sci 2007, 104:116-121.
24. Niwa M., Nitta A., Yamada K., Yakajima A., Saito K., Seishima M., et al. Tumor necrosis factor-alpha and its inducer inhibit morphine-induced rewarding effects and sensitization. Biol Psychiatry 2007, 62:658-668.
25. Utsuyama M., Hirokawa K. Differential expression of various cytokine receptors in the brain after stimulation with LPS in young and old mice. Exp Gerontol 2002, 37:411-420.
26. Biber K., Pinto-Duarte A., Wittendorp M.C., Dolga A.M., Fernandes C.C., von Frijtaq Drabbe Kunzel, et al. Interleukin-6 upregulates neuronal adenosine A1 receptors: implications for neuromodulation and neuroprotection. Neuropsychopharmacology 2008, 33:2237-2250.
27. Stahl S.M. Stahl's essential psychopharmacology 2008, Cambridge University Press, New York, USA. 3rd ed.
28. Winblad B., Poritis N. Memantine in severe dementia: results of the 9M-best study (benefit and efficacy in severely demented patients during treatment with memantine. Int J Geriatr Psychiatry 1999, 14:135-146.
29. Reisberg B., Doody R., Stoffler A., Schmitt F., Ferris S., Mobius H.J. Memantine in moderate-to-severe Alzheimer's disease. New Eng J Med 2003, 348:1333-1341.